Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quinidine-digoxin interaction: time course and pharmacokinetics

E B Leahey, J T Bigger, V P Butler

    The American Journal of Cardiology
    |December 1, 1981
    PubMed
    Summary

    Quinidine significantly increases serum digoxin levels by reducing its clearance, especially renal clearance. This drug interaction necessitates careful monitoring of digoxin concentrations during concurrent quinidine therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.

    Applied clinical informatics·2014
    Same author

    A potential krimpsiekte vaccine.

    The Onderstepoort journal of veterinary research·2008
    Same author

    Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias.

    Journal of cardiovascular pharmacology and therapeutics·2002
    Same author

    Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

    The American journal of psychiatry·2001
    Same author

    Importance of QT interval determination and renal function assessment during antiarrhythmic drug therapy.

    Journal of cardiovascular pharmacology and therapeutics·2001
    Same author

    Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials.

    Circulation·2001

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy
    • Cardiology

    Background:

    • Digoxin is a crucial medication for managing heart conditions.
    • Quinidine is an antiarrhythmic drug that can interact with other medications.
    • Understanding drug interactions is vital for patient safety and effective treatment.

    Purpose of the Study:

    • To investigate the impact of quinidine on digoxin pharmacokinetics.
    • To quantify changes in digoxin serum levels and clearance during quinidine treatment.
    • To determine if the quinidine dose affects its interaction with digoxin.

    Main Methods:

    • Studied 18 patients receiving digoxin and initiating quinidine therapy.
    • Monitored serum digoxin concentrations over time.
    • Conducted kinetic studies in normal volunteers receiving low-dose (800 mg/day) or high-dose (1,600 mg/day) quinidine.

    Related Experiment Videos

    Main Results:

    • Serum digoxin levels significantly increased within 24 hours of starting quinidine, reaching a steady state in 48 hours.
    • Quinidine reduced total digoxin clearance by 30-36%, renal clearance by 32-54%, and non-renal clearance by 22-29%.
    • Reductions in digoxin volume of distribution and renal clearance were dose-dependent on quinidine levels; non-renal clearance changes were not.

    Conclusions:

    • Quinidine significantly alters digoxin pharmacokinetics, leading to higher serum concentrations.
    • The interaction primarily involves reduced digoxin clearance, particularly renal clearance.
    • Clinicians should closely monitor digoxin levels when initiating quinidine therapy due to this significant drug interaction.